Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Tempest Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 19 | 15 | −4 |
| Shares | 2.35M | 2.10M | −248.8K (−10.6%) |
| Value | $12.4M | $7.12M | −$5.29M (−42.6%) |
New holders (2)
Institutions that held Tempest Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 10,100 | $34.0K | 0.00% |
| JPMorgan Chase & Co | 132 | $0 | 0.00% |
Sold out (6)
Institutions that held Tempest Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEA Management Company, LLC | 117,785 | $622.0K |
| Maven Securities LTD | 77,377 | $409.0K |
| Millennium Management LLC | 14,628 | $77.0K |
| Group One Trading, L.P. | 192 | $1.00K |
| Baystate Wealth Management LLC | 5 | $0 |
| EverSource Wealth Advisors, LLC | 4 | $0 |